Notice2024-25552
Agency Forms Undergoing Paperwork Reduction Act Review
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
November 4, 2024
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 213 (Monday, November 4, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 213 (Monday, November 4, 2024)]
[Notices]
[Pages 87582-87585]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-25552]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-25-0666]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``National Healthcare Safety Network'' to the
Office of Management and Budget (OMB) for review and approval. CDC
previously published a ``Proposed Data Collection Submitted for Public
Comment and Recommendations'' notice on April 23, 2024 to obtain
comments from the public and affected agencies. CDC received two
comments related to the previous notice. This notice serves to allow an
additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the
[[Page 87583]]
proposed information collection should be sent within 30 days of
publication of this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. Find
this particular information collection by selecting ``Currently under
30-day Review--Open for Public Comments'' or by using the search
function. Direct written comments and/or suggestions regarding the
items contained in this notice to the Attention: CDC Desk Officer,
Office of Management and Budget, 725 17th Street NW, Washington, DC
20503 or by fax to (202) 395-5806. Provide written comments within 30
days of notice publication.
Proposed Project
National Healthcare Safety Network (NHSN) (OMB Control No. 0920-
0666, Exp. 06/30/2026)--Revision--National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The Division of Healthcare Quality Promotion (DHQP), National
Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers
for Disease Control and Prevention (CDC) collects data from healthcare
facilities in the National Healthcare Safety Network (NHSN) under OMB
Control Number 0920-0666. NHSN provides facilities, health departments,
states, regions, and the nation with data necessary to identify problem
areas, measure the progress of prevention efforts, and ultimately
eliminate healthcare-associated infections (HAIs) nationwide. NHSN also
allows healthcare facilities to track blood safety errors and various
HAI prevention practice methods such as healthcare personnel influenza
vaccine status and corresponding infection control adherence rates.
The proposed changes in this new ICR includes revisions made to 74
approved NHSN data collection tools and 10 new forms, for a total of 84
forms in this package. CDC requests OMB approval for an estimated
4,398,109 annual burden hours. There is no cost to respondents other
than their time to participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Form number & name Number of responses per per response
respondents respondent (min./hour 60)
----------------------------------------------------------------------------------------------------------------
1..................................... 57.100 NHSN Registration 2,000 1 5/60
Form.
2..................................... 57.101 Facility Contact 2,000 1 10/60
Information.
3..................................... 57.102 NHSN Help Desk 26,400 1 2/60
Customer Satisfaction
Survey.
4..................................... 57.103 Patient Safety 5,400 1 137/60
Component--Annual
Hospital Survey.
5..................................... 57.104 NHSN Facility 800 1 5/60
Administrator Change
Request Form.
6..................................... 57.105 Group Contact 1,000 1 5/60
Information.
7..................................... 57.106 Patient Safety 7,821 12 15/60
Monthly Reporting Plan.
8..................................... 57.108 Primary 6,000 12 42/60
Bloodstream Infection
(BSI).
9..................................... 57.111 Pneumonia (PNEU). 1,800 2 34/60
10.................................... 57.112 Ventilator- 5,463 8 32/60
Associated Event (VAE).
11.................................... 57.113 Pediatric 334 1 34/60
Ventilator-Associated
Event (PedVAE).
12.................................... 57.114 Urinary Tract 6,000 12 24/60
Infection (UTI).
13.................................... 57.115 Custom Event..... 600 91 39/60
14.................................... 57.116 Denominators for 1,100 12 240/60
Neonatal Intensive Care
Unit (NICU).
15.................................... 57.117 Denominators for 500 12 300/60
Specialty Care Area
(SCA)/Oncology (ONC).
16.................................... 57.118 Denominators for 5,500 60 300/60
Intensive Care Unit
(ICU)/Other locations
(not NICU or SCA).
17.................................... 57.120 Surgical Site 3,800 12 14/60
Infection (SSI).
18.................................... 57.121 Denominator for 3,800 12 14/60
Procedure.
19.................................... 57.122 HAI Progress 55 1 50/60
Report State Health
Department Survey.
20.................................... 57.123 Antimicrobial Use 2,200 1 4,800/60
and Resistance (AUR)--
Microbiology Data
Electronic Upload
Specification Tables--
Initial Set-up.
57.123 Antimicrobial Use 3,300 2 120/60
and Resistance (AUR)--
Microbiology Data
Electronic Upload
Specification Tables--
Yearly Maintenance.
57.123 Antimicrobial Use 5,500 12 5/60
and Resistance (AUR)--
Microbiology Data
Electronic Upload
Specification Tables--
Monthly.
21.................................... 57.124 Antimicrobial Use 1,500 1 2,400/60
and Resistance (AUR)--
Pharmacy Data
Electronic Upload
Specification Tables--
Initial Set-up.
57.124 Antimicrobial Use 4,000 1 120/60
and Resistance (AUR)--
Pharmacy Data
Electronic Upload
Specification Tables--
Yearly Maintenance.
57.124 Antimicrobial Use 5,500 12 5/60
and Resistance (AUR)--
Pharmacy Data
Electronic Upload
Specification Tables--
Monthly.
22.................................... 57.125 Central Line 500 213 26/60
Insertion Practices
Adherence Monitoring.
23.................................... 57.126 MDRO or CDI 720 12 34/60
Infection Form.
24.................................... 57.127 MDRO and CDI 5,500 29 15/60
Prevention Process and
Outcome Measures
Monthly Monitoring.
25.................................... 57.128 Laboratory- 4,800 12 24/60
identified MDRO or CDI
Event.
26.................................... 57.129 Adult Sepsis..... 50 12 28/60
27.................................... 57.130 Pathogens of High 3,650 365 30/60
Consequence.
28.................................... 57.132 Patient Safety 5,500 1 1,620/60
Component Digital
Measure Reporting Plan
(HOB, HT-CDI, VTE,
Adult Sepsis, RPS,
NVAP)-IT Initial Set up.
57.132 Patient Safety 5,500 1 1,200/60
Component Digital
Measure Reporting Plan
(HOB, HT-CDI, VTE,
Adult Sepsis, RPS,
NVAP)-IT Yearly
Maintenance.
57.132 Patient Safety 5,500 4 10/60
Component Digital
Measure Reporting Plan
(HOB, HT-CDI, VTE,
Adult Sepsis, RPS,
NVAP)-Infection
Preventionist.
57.132 Patient Safety 5,500 365 2/60
Digital Reporting Plan
(RPS CSV).
[[Page 87584]]
29.................................... 57.133 Patient Safety 3,500 1 10/60
Attestation.
30.................................... 57.137 Long-Term Care 6,270 1 135/60
Facility Component--
Annual Facility Survey.
31.................................... 57.138 Laboratory- 286 24 23/60
identified MDRO or CDI
Event for LTCF.
32.................................... 57.139 MDRO and CDI 738 12 10/60
Prevention Process
Measures Monthly
Monitoring for LTCF.
33.................................... 57.140 Urinary Tract 373 24 38/60
Infection (UTI) for
LTCF.
34.................................... 57.141 Monthly Reporting 546 12 5/60
Plan for LTCF.
35.................................... 57.142 Denominators for 724 12 35/60
LTCF Locations.
36.................................... 57.143 Prevention 434 12 5/60
Process Measures
Monthly Monitoring for
LTCF.
37.................................... 57.145 Long Term Care 16,500 12 5/60
Antimicrobial Use (LTC-
AU) Module CDA.
38.................................... 57.150 LTAC Annual 395 1 102/60
Survey.
39.................................... 57.151 Rehab Annual 395 1 102/60
Survey.
40.................................... 57.211 Weekly Healthcare 117 12 25/60
Personnel Influenza
Vaccination Cumulative
Summary for Non-Long-
Term Care Facilities-
Manual.
57.211 Weekly Healthcare 3,080 12 20/60
Personnel Influenza
Vaccination Cumulative
Summary for Non-Long-
Term Care Facilities-
.CSV.
41.................................... 57.214 Annual Healthcare 22,000 1 120/60
Personnel Influenza
Vaccination Summary-
Manual.
57.214 Annual Healthcare 1,920 1 55/60
Personnel Influenza
Vaccination Summary-
.CSV.
42.................................... 57.215 Seasonal Survey 15,426 1 45/60
on Influenza
Vaccination Programs
for Healthcare
Personnel.
43.................................... 57.300 Hemovigilance 63 1 86/60
Module Annual Survey.
44.................................... 57.301 Hemovigilance 108 12 1/60
Module Monthly
Reporting Plan.
45.................................... 57.302 Hemovigilance 9 12 30/60
Module Monthly Incident
Summary.
46.................................... 57.303 Hemovigilance 102 12 70/60
Module Monthly
Reporting Denominators.
47.................................... 57.305 Hemovigilance 13 77 10/60
Incident.
48.................................... 57.306 Hemovigilance 20 1 35/60
Module Annual Survey--
Non-acute care facility.
49.................................... 57.307 Hemovigilance 8 2 22/60
Adverse Reaction--Acute
Hemolytic Transfusion
Reaction.
50.................................... 57.308 Hemovigilance 50 11 22/60
Adverse Reaction--
Allergic Transfusion
Reaction.
51.................................... 57.309 Hemovigilance 9 2 20/60
Adverse Reaction--
Delayed Hemolytic
Transfusion Reaction.
52.................................... 57.310 Hemovigilance 19 5 20/60
Adverse Reaction--
Delayed Serologic
Transfusion Reaction.
53.................................... 57.311 Hemovigilance 85 13 20/60
Adverse Reaction--
Febrile Non-hemolytic
Transfusion Reaction.
54.................................... 57.312 Hemovigilance 23 3 20/60
Adverse Reaction--
Hypotensive Transfusion
Reaction.
55.................................... 57.313 Hemovigilance 2 2 20/60
Adverse Reaction--
Infection.
56.................................... 57.314 Hemovigilance 1 1 20/60
Adverse Reaction--Post
Transfusion Purpura.
57.................................... 57.315 Hemovigilance 18 3 20/60
Adverse Reaction--
Transfusion Associated
Dyspnea.
58.................................... 57.316 Hemovigilance 1 1 20/60
Adverse Reaction--
Transfusion Associated
Graft vs. Host Disease.
59.................................... 57.317 Hemovigilance 1 1 20/60
Adverse Reaction--
Transfusion Related
Acute Lung Injury.
60.................................... 57.318 Hemovigilance 40 4 21/60
Adverse Reaction--
Transfusion Associated
Circulatory Overload.
61.................................... 57.319 Hemovigilance 15 3 20/60
Adverse Reaction--
Unknown Transfusion
Reaction.
62.................................... 57.320 Hemovigilance 39 3 20/60
Adverse Reaction--Other
Transfusion Reaction.
63.................................... 57.400 Outpatient 350 1 10/60
Procedure Component--
Annual Ambulatory
Surgery Center Survey.
64.................................... 57.401 Outpatient 350 12 10/60
Procedure Component--
Monthly Reporting Plan.
65.................................... 57.402 Outpatient 50 1 43/60
Procedure Component
Same Day Outcome
Measures.
66.................................... 57.403 Outpatient 50 400 20/60
Procedure Component--
Denominators for Same
Day Outcome Measures.
67.................................... 57.404 Outpatient 300 100 23/60
Procedure Component--
SSI Denominator.
68.................................... 57.405 Outpatient 300 36 40/60
Procedure Component--
Surgical Site (SSI)
Event.
69.................................... 57.408 Monthly Survey 2,500 12 300/60
Patient Days & Nurse
Staffing.
70.................................... 57.500 Outpatient 6,900 1 150/60
Dialysis Center
Practices Survey.
71.................................... 57.501 Dialysis Monthly 7,400 12 5/60
Reporting Plan.
72.................................... 57.502 Dialysis Event... 7,400 30 50/60
73.................................... 57.503 Denominator for 7,400 12 10/60
Outpatient Dialysis.
74.................................... 57.504 Prevention 1,730 12 60/60
Process Measures
Monthly Monitoring for
Dialysis.
75.................................... 57.507 Home Dialysis 550 1 65/60
Center Practices Survey.
76.................................... 57.600 Neonatal 5,500 1 1,620/60
Component FHIR Measure-
Late Onset Sepsis
Meningitis (LOSMEN)
Module-IT Initial Set
up.
57.600 Neonatal 5,500 1 1,200/60
Component FHIR Measure-
Late Onset Sepsis
Meningitis (LOSMEN)
Module-IT Yearly
Maintenance.
57.600 Neonatal 5,500 6 6/60
Component FHIR Measure-
Late Onset Sepsis
Meningitis (LOSMEN)
Module-Infection
Preventionist.
57.600 Neonatal 5,500 12 2/60
Component Late Onset
Sepsis Meningitis
(LOSMEN) Module CDA
Data Collection-
Infection Preventionist.
77.................................... 57.601 Late Onset Sepsis/ 300 6 5/60
Meningitis Denominator
Form: Late Onset Sepsis/
Meningitis Denominator
Form: Data Table for
monthly electronic
upload.
[[Page 87585]]
78.................................... 57.602 Late Onset Sepsis/ 300 6 6/60
Meningitis Event Form:
Data Table for Monthly
Electronic Upload.
79.................................... 57.700 Medication Safety- 5,500 1 1,620/60
Digital Measure
Reporting Plan (HYPO,
HAKI, ORAE)--IT Initial
Set up.
57.700 Medication Safety- 5,500 1 1,200/60
Digital Measure
Reporting Plan (HYPO,
HAKI, ORAE)--IT Yearly
Maintenance.
57.700 Medication Safety- 5,500 4 10/60
Digital Measure
Reporting Plan (HYPO,
HAKI, ORAE)--Infection
Preventionist.
80.................................... 57.701 Glycemic Control 10 1 180/60
Module-HYPO Annual
Survey.
81.................................... 57.800 Billing Code 5,500 4 5/60
Data: 837I Upload.
82.................................... 57.801 External 20 2 15/60
Validation Summary
Report.
83.................................... 57.802 Bed Capacity-IT 25 1 20/60
Initial Set Up.
84.................................... 57.803 All Hazards...... 540 365 5/60
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2024-25552 Filed 11-1-24; 8:45 am]
BILLING CODE 4163-18-P
</pre></body>
</html>Indexed from Federal Register on November 4, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.